Prognostic impact of tumor size on cancer-specific survival for postoperative WHO grade II oligodendroglioma: a SEER-based study.

in Frontiers in surgery by Qin Lu, Yongyan Wu, Yonglin Xie, Shuxu Yang, Hongchuan Jin

TLDR

  • The study identified four prognostic factors for cancer-specific survival in postoperative WHO grade II oligodendroglioma patients: age, sex, extent of resection, and tumor size, with a tumor size of 60 mm serving as an optimal cut-off point.

Abstract

WHO grade II oligodendroglioma (OG/II) is a rare primary brain tumor with various outcomes. Our study aims to investigate prognostic factors for postoperative OG/II patients and then evaluate the instructional value of tumor size. We retrospectively studied the cases from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox analyses and Kaplan-Meier survival curves were used to identify and assess prognostic factors. The optimal cut-off value of tumor size was determined by X-tile analysis and verified by multivariate analyses. Subsequently, Subgroup analyses were performed based on tumor size. 676 OG/II patients were enrolled in our study. Multivariate Cox analyses revealed that age > 60 (HR 3.52), male (HR 1.48), total resection (HR 0.38), and tumor size (HR 2.04) were independent factors in predicting cancer-specific survival (CCS). The optimal cut-off value for tumor size was 60 mm. Patients with tumor size less than 60 mm, age > 60 (HR 3.82), and radiation (HR 1.58) were associated with worse CSS, while total resection (HR 0.35) was associated with better CSS. Lastly, a tumor size-based nomogram was established objectively and accurately. Our study identified four crucial prognostic factors related to CSS in postoperative OG/II patients: age, sex, the extent of recession, and tumor size. A tumor size of 60 mm was an optimal cut-off point for dividing patients into low and high-risk groups. Patients in the low-risk group may not benefit from extended resection and radiation. Tumor size can be a valuable factor for making therapeutic schedules.

Overview

  • The study investigates prognostic factors for postoperative WHO grade II oligodendroglioma (OG/II) patients, focusing on tumor size as an instructional value.
  • The study retrospectively analyzed the cases from the Surveillance, Epidemiology, and End Results (SEER) database.
  • The primary objective is to identify and assess prognostic factors for cancer-specific survival (CSS) in postoperative OG/II patients.

Comparative Analysis & Findings

  • Multivariate Cox analyses revealed that age > 60, male, total resection, and tumor size were independent factors in predicting CCS.
  • The optimal cut-off value for tumor size was determined to be 60 mm.
  • Subgroup analyses showed that patients with tumor size less than 60 mm, age > 60, and radiation were associated with worse CSS, while total resection was associated with better CSS.

Implications and Future Directions

  • The study identified four crucial prognostic factors related to CSS in postoperative OG/II patients: age, sex, extent of resection, and tumor size.
  • Tumor size can be a valuable factor for making therapeutic schedules, with a tumor size of 60 mm serving as an optimal cut-off point for dividing patients into low and high-risk groups.
  • Future studies could explore the use of tumor size-based nomograms in clinical practice and investigate the potential benefits and limitations of using tumor size as a therapeutic decision-making tool.